Global Minimally Invasive Neurosurgical Systems Market: Analysis and Forecast, 2020-2030

October 2020 | 208 pages | ID: G4555B8312F5EN
BIS Research Inc.

Abstracts

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.

Market Report Coverage - Minimally Invasive Neurosurgical Systems

Market Segmentation

• Neuromicroscopy
• Neuronavigation
• Optical Neuronavigation Systems
• Electromagnetic Neuronavigation Systems
• Neuroendoscopy
• Rigid Neuroendoscopy Systems
• Flexible Neuroendoscopy Systems
• Neurosurgical Robotics
• Systems
• Instruments and Accessories
• Services

Regional Segmentation

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Netherlands
• Switzerland
• Rest-of-Europe
• Asia-Pacific
• Japan
• China
• South Korea
• India
• Australia and New Zealand
• Singapore
• Rest-of-Asia-Pacific
• Rest-of-the-World (Latin America and Middle East and Africa)

Growth Drivers

• Increasing Elderly Population on the Global Level
• Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
• Availability of Technological Advanced Products in the Field of Neurosurgical Procedures

Market Challenges

• Shortage of Skilled Professionals
• Restrictive Reimbursement Landscape

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems
• Development of Augmented Reality in the Operating Field

Key Companies Profiled

Corindus vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation

Key Questions Answered in this Report:

• What is the current market size and future potential of the minimally invasive neurosurgical products?
• What is the current market share and growth share of the different products in the market?
• What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive neurosurgical systems?
• What are the major market drivers, restraints, and opportunities in the global minimally invasive neurosurgical systems market?
• What is the impact of the COVID-19 pandemic on the market?
• Which technology is being researched and worked upon to improve the neurosurgical systems?
• Who are the leading players holding dominating shares in the global minimally invasive neurosurgical systems market?
• What are the key development and strategies incorporated by the players of the global minimally invasive neurosurgical systems market to sustain the competition and retain their supremacy?
• Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive neurosurgical systems market?

Overview on the Global Minimally Invasive Neurosurgical Systems Market

Technological advancements in neurosurgical systems and instruments have led to major breakthroughs and disruptive phases in the healthcare landscape across the world. The inventions of the digital camera further aiding in the visualization of the operating field and smaller surgical instruments, which can be passed through endoscopes, produces less trauma to a patient due to small incisions on the skull. Thus, the preference for minimally invasive neurosurgeries continued to grow over the decades, this led to the emergence of robotic-assisted surgeries because of the need for millimeter accuracy and precision, which cannot be done freehand by neurosurgeons. The idea of robotic-assisted neurosurgical procedures is being driven by the increasing need for using multiple surgical instruments through multiple access ports of the endoscopes to support minimally invasive neurosurgeries.

Global Minimally Invasive Neurosurgical Systems Market Forecast, 2020-2030

The global minimally invasive neurosurgical systems market was valued at $419.8 million in 2019 and is anticipated to reach $1,217.4 million by 2030, growing at a CAGR of 11.9% during the forecast period 2020-2030.

The evolution of technologies and methodologies has a huge impact on the global minimally invasive neurosurgical systems market. Several factors such as the shift in preference for safer options than open brain surgeries, increasing preference for surgical instruments with more dexterity, increasing affordability of the procedure, and technological advances in the field of Artificial Intelligence (AI), Augmented Reality (AR), haptics, and telesurgery are expected to play a key role in the growth of the market. The neurosurgical robot is likely to grow because of a more connected interface, motion scaling, and tremor filtration. The high installation and maintenance cost of neurosurgical robotic systems is one of the key factors restraining the growth in the adoption of surgical robotics technology. The neurosurgical systems like neuroendoscopy, neuronavigation, and neuromicroscopy will see steady growth due to the upgradation in the technologies they use. Additionally, a lack of skilled professionals will be a challenge to the growth of this market.

Competitive Landscape

The global minimally invasive neurosurgical systems market consists of large and new entrant manufacturers and vendors. Presently, with the increasing adoption of neurosurgical robotics systems and neuronavigation systems in healthcare, the manufacturers in the market have a decent number of opportunities to expand their offerings and to make a strong foothold in the market.

During January 2015 – December 2020, the market witnessed approximately 12 new offerings, seven partnerships, alliances and business expansions, 17 regulatory and legal approvals, four funding activities, and five mergers and acquisitions. Most of the manufacturers in the market acquires and partnerships with not only other companies but also the university and research institutions as the key strategies to develop a new version of neurosurgical systems to attain a strong financial position in the market.

The key players contributing to the global minimally invasive neurosurgical systems market are Corindus Vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation.

Contents

1 PRODUCT DEFINITION

2 SCOPE OF RESEARCH STUDY

2.1 Key Questions Answered in the Report
2.2 Forecast Period Selection Criteria

3 RESEARCH METHODOLOGY

3.1 Primary Research
3.2 Secondary Research
3.3 Data Sources and Categorization
3.4 Market Estimation and Forecast Methodology
3.5 Data Triangulation

4 COMPETITIVE LANDSCAPE

4.1 Key Developments and Strategies
  4.1.1 Regulatory and Legal
  4.1.2 New Offerings
  4.1.3 Partnerships, Alliances, and Business Expansions
  4.1.4 Mergers and Acquisitions
  4.1.5 Funding Activities
4.2 Market Share Analysis
  4.2.1 Company
  4.2.2 Neuromicroscopy
  4.2.3 Neuronavigation
  4.2.4 Neuroendoscopy
  4.2.5 Neurosurgical Robotics
4.3 Growth Share Analysis
  4.3.1 Product Type
  4.3.2 Region

5 INDUSTRY INSIGHTS

5.1 Legal Regulations
  5.1.1 U.S.
  5.1.2 European Union (EU)
  5.1.3 China
  5.1.4 Japan
5.2 Impact of COVID-19
5.3 Awaited Technological Developments
  5.3.1 Age of Augmented Reality (AR) Integration
5.4 Patent Analysis
  5.4.1 Patent Filing Trends
  5.4.2 Patent Filing Trend, by Product Type
  5.4.3 Patent Filing Trend, by Country
  5.4.4 Impact of Patent Expiration
5.5 Minimally Invasive Surgeries: Opportunity Analysis
  5.5.1 Pre-COVID-19 Scenario
  5.5.2 Post-COVID-19 Scenario

6 MARKET DYNAMICS

6.1 Impact Analysis
6.2 Market Drivers
  6.2.1 Increasing Elderly Population on the Global Level Propels the Demand for Minimally Invasive Neurosurgical Procedures
  6.2.2 Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
  6.2.3 Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
6.3 Market Restraints
  6.3.1 Lack of Skilled Professionals
  6.3.2 Restrictive Reimbursement Framework
6.4 Market Opportunities
  6.4.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
    6.4.1.1 Advantages of Long-Distance Teleoperated Surgical Robotics

7 GLOBAL MINIMALLY INVASIVE NEUROSURGICAL SYSTEMS MARKET SCENARIO

7.1 Global Market Outlook, 2019-2030
7.2 Key Findings
7.3 Assumptions and Limitations

8 GLOBAL MINIMALLY INVASIVE NEUROSURGICAL SYSTEMS MARKET (BY PRODUCT TYPE), 2019-2030

8.1 Market Overview
8.2 Neuromicroscopy
  8.2.1 Overview
  8.2.2 Market Size and Forecast
8.3 Neuronavigation
  8.3.1 Overview
  8.3.2 Market Size and Forecast
  8.3.3 Optical Neuronavigation Systems
  8.3.4 Electromagnetic Neuronavigation Systems
8.4 Neuroendoscopy
  8.4.1 Overview
  8.4.2 Market Size and Forecast
  8.4.3 Rigid Neuroendoscopy Systems
  8.4.4 Flexible Neuroendoscopy Systems
8.5 Neurosurgical Robotics
  8.5.1 Overview
  8.5.2 Market Size and Forecast
  8.5.3 Systems (Capital Equipment)
  8.5.4 Instruments and Accessories
  8.5.5 Services

9 GLOBAL MINIMALLY INVASIVE NEUROSURGICAL SYSTEMS MARKET (BY REGION), 2019-2030

9.1 Market Overview
9.2 North America
  9.2.1 Opportunity Assessment
  9.2.2 Market Size and Forecast
  9.2.3 U.S.
  9.2.4 Canada
9.3 Europe
  9.3.1 Opportunity Assessment
  9.3.2 Market Size and Forecast
  9.3.3 Germany
  9.3.4 France
  9.3.5 U.K.
  9.3.6 Italy
  9.3.7 Spain
  9.3.8 Netherlands
  9.3.9 Switzerland
  9.3.10 Rest-of-Europe
9.4 Asia-Pacific
  9.4.1 Opportunity Assessment
  9.4.2 Market Size and Forecast
  9.4.3 Japan
  9.4.4 China
  9.4.5 South Korea
  9.4.6 India
  9.4.7 Australia and New Zealand
  9.4.8 Singapore
  9.4.9 Rest-of-Asia-Pacific
9.5 Rest-of-the-World (Latin America and Middle East and Africa)
  9.5.1 Opportunity Assessment
  9.5.2 Market Size and Forecast

10 COMPANY PROFILES

10.1 Overview
10.2 Competitors Snapshot
10.3 B. Braun Melsungen AG
  10.3.1 Company Overview
  10.3.2 Company Description
  10.3.3 Financials
  10.3.4 SWOT Analysis
10.4 Brainlab AG
  10.4.1 Company Overview
  10.4.2 Company Description
  10.4.3 SWOT Analysis
10.5 Carl Zeiss Meditec AG
  10.5.1 Company Overview
  10.5.2 Company Description
  10.5.3 Financials
  10.5.4 SWOT Analysis
10.6 Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
  10.6.1 Company Overview
  10.6.2 Company Description
  10.6.3 Financials
  10.6.4 SWOT Analysis
10.7 Haag-Streit Holding AG (Metall Zug AG)
  10.7.1 Company Overview
  10.7.2 Company Description
  10.7.3 Financials
  10.7.4 SWOT Analysis
10.8 Karl Storz SE & Co. KG
  10.8.1 Company Overview
  10.8.2 Company Description
  10.8.3 SWOT Analysis
10.9 Leica Microsystems AG (Danaher Corporation)
  10.9.1 Company Overview
  10.9.2 Company Description
  10.9.3 Financials
  10.9.4 SWOT Analysis
10.10 Medtronic plc
  10.10.1 Company Overview
  10.10.2 Company Description
  10.10.3 Financials
  10.10.4 SWOT Analysis
10.11 Microbot Medical, Inc.
  10.11.1 Company Overview
  10.11.2 Company Description
  10.11.3 SWOT Analysis
10.12 Monteris Medical Corporation
  10.12.1 Company Overview
  10.12.2 Company Description
  10.12.3 SWOT Analysis
10.13 Olympus Corporation
  10.13.1 Company Overview
  10.13.2 Company Description
  10.13.3 Financials
  10.13.4 SWOT Analysis
10.14 Renishaw plc
  10.14.1 Company Overview
  10.14.2 Company Description
  10.14.3 Financials
  10.14.4 SWOT Analysis
10.15 Stryker Corporation
  10.15.1 Company Overview
  10.15.2 Company Description
  10.15.3 Financials
  10.15.4 SWOT Analysis
10.16 Synaptive Medical, Inc.
  10.16.1 Company Overview
  10.16.2 Company Description
  10.16.3 SWOT Analysis
10.17 Zimmer Biomet Holdings, Inc.
  10.17.1 Company Overview
  10.17.2 Company Description
  10.17.3 Financials
  10.17.4 SWOT Analysis

List Of Tables

LIST OF TABLES

Table 1: Impact of Market Drivers
Table 2: Impact of Market Restraints
Table 5.1: Minimally Invasive Neurosurgical Systems: FDA Product Classification
Table 6.1: Impact Analysis: Market Drivers
Table 6.2: Impact Analysis: Market Restraints
Table 9.1: North America Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.2: U.S. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.3: Canada Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.4: Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.5: Germany Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.6: France Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.7: U.K. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.8: Italy Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.9: Spain Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.10: Netherlands Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.11: Switzerland Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.12: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.13: Asia-Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.14: Japan Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.15: China Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.16: South Korea Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.17: India Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.18: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.19: Singapore Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.20: Rest-of-Asia Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.21: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030

List Of Figures

LIST OF FIGURES

Figure 1: Evolution of Surgery
Figure 2: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 3: Company Share Analysis, 2019 and 2020
Figure 4: Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019 and 2030
Figure 5: Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019, 2025, and 2030
Figure 6: Global Minimally Invasive Neurosurgical Systems Market Growth (by Region), 2019, 2025, and 2030
Figure 7: Key Strategies Incorporated by the Key Players (January 2015–December 2020)
Figure 3.1: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-Up Approach
Figure 4.1: Share of Key Developments and Strategies (by Category), January 2015 – December 2020
Figure 4.2: Number of Key Developments and Strategies (by Year), January 2015– December 2020
Figure 4.3: Number of Key Developments and Strategies (by Regulatory and Legal Activities), January 2015–December 2020
Figure 4.4: Number of Key Developments and Strategies (by New Offerings), January 2015–December 2020
Figure 4.5: Market Share Analysis (Company), 2019 and 2020
Figure 4.6: Growth Share Analysis (by Product Type), 2019-2030
Figure 4.7: Growth Share Analysis (by Region), 2019-2030
Figure 5.1: Regulatory Process for Medical Devices in the U.S.
Figure 5.2: MDR Transitional Provisions (EU)
Figure 5.3: Timeline and Impact of MDR (EU)
Figure 5.4: Regulatory Process for Medical Devices in European Union
Figure 5.5: Regulatory Process for Medical Devices in the China
Figure 5.6: Regulatory Process for Medical Devices in Japan
Figure 5.7: Patent Filing Trend (by Year), January 2015 - September 2020
Figure 5.8: Percentage of Patent Filed in Different Technological Area, (January 2015–September 2020)
Figure 5.9: Patent Filing Trend (by Year), January 2015–September 2020
Figure 5.10: Minimally Invasive Surgery – Pre-COVID-19 Scenario
Figure 5.11: Number of Elective Surgical Procedures Cancelled due to COVID?19 (by Region)
Figure 6.1: Market Dynamics
Figure 6.2: Global Prevalence of Neurological Disorders (by Age-Group), 2013-2017
Figure 6.3: Global Deaths due to Neurological Disorders (by Age-Group), 2013-2017
Figure 6.4: Advantages of Minimally Invasive Surgical Procedures
Figure 6.5: Overview of Telesurgery Workflow
Figure 6.6: Telesurgery: Bridging the Gap Associated with Healthcare Accessibility
Figure 7.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 7.2: Global Market Incremental Revenue Opportunity Analysis, 2019-2030
Figure 8.1: Global Minimally Invasive Neurosurgical Systems Market Segmentation
Figure 8.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Product Type), 2019 and 2030
Figure 8.3: Global Neuromicroscopy Market, 2019-2030
Figure 8.4: Neuronavigation: Market Segmentation:
Figure 8.5: Global Neuronavigation Market, 2019-2030
Figure 8.6: Global Neuronavigation Market Share, 2019 and 2030
Figure 8.7: Global Optical Neuronavigation Systems Market, 2019-2030
Figure 8.8: Global Electromagnetic Neuronavigation Systems Market, 2019-2030
Figure 8.9: Market Potential of Endoscopy Systems (by Application)
Figure 8.10: Neuroendoscopy: Market Segmentation:
Figure 8.11: Global Neuroendoscopy Market, 2019-2030
Figure 8.12: Global Neuroendoscopy Market Share, 2019 and 2030
Figure 8.13: Global Rigid Neuroendoscopy Systems Market, 2019-2030
Figure 8.14: Global Flexible Neuroendoscopy Systems Market, 2019-2030
Figure 8.15: Neurosurgical Robotics: Market Segmentation:
Figure 8.16: Global Neurosurgical Robotics Market, 2019-2030
Figure 8.17: Global Neurosurgical Robotics Market Share, 2019 and 2030
Figure 8.18: Global Neurosurgical Robotics Market (Systems), 2019-2030
Figure 8.19: Global Neurosurgical Robotics Market (Instruments and Accessories), 2019-2030
Figure 8.20: Global Neurosurgical Robotics Market (Services), 2019-2030
Figure 9.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Region), 2019 and 2030
Figure 9.3: North America: Incremental Revenue Opportunity, 2019-2030
Figure 9.4: North America Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.5: North America Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.6: U.S. Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.7: Canada Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.8: Europe: Incremental Revenue Opportunity, 2019-2030
Figure 9.9: Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.10: Europe Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.11: Germany Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.12: France Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.13: U.K. Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.14: Italy Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.15: Spain Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.16: Netherlands Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.17: Switzerland Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.18: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.19: Asia-Pacific: Incremental Revenue Opportunity, 2019-2030
Figure 9.20: Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.21: Asia-Pacific Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.22: Japan Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.23: China Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.24: South Korea Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.25: India Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.26: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.27: Singapore Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.28: Rest-of-Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.29: Rest-of-the-World: Incremental Revenue Opportunity, 2019-2030
Figure 9.30: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 10.1: Global Minimally Invasive Neurosurgical Systems Market: Key Companies
Figure 10.2: B. Braun Melsungen AG: Overall Financials ($Million), 2017-2019
Figure 10.3: B. Braun Melsungen AG: Net Revenue (by Segment), 2017-2019
Figure 10.4: B. Braun Melsungen AG: Net Revenue (by Region), 2017-2019
Figure 10.5: Carl Zeiss Meditec AG: Overall Financials ($Million), 2018-2020
Figure 10.6: Carl Zeiss Meditec AG: Net Revenue (by Segment), 2018-2020
Figure 10.7: Carl Zeiss Meditec AG: Net Revenue (by Region), 2018-2020
Figure 10.8: Corindus Vascular Robotics, Inc.: Overall Financials ($Million), 2016-2018
Figure 10.9: Corindus Vascular Robotics, Inc.: Net Revenue (by Segment), 2016-2018
Figure 10.10: Corindus Vascular Robotics, Inc.: Net Revenue (by Region), 2016-2018
Figure 10.11: Metall Zug AG: Overall Financials ($Million), 2017-2019
Figure 10.12: Metall Zug AG: Net Revenue (by Segment), 2017-2019
Figure 10.13: Metall Zug AG: Net Revenue (by Region), 2018-2019
Figure 10.14: Danaher Corporation: Overall Financials ($Million), 2017-2019
Figure 10.15: Danaher Corporation: Net Revenue (by Segment), 2017-2019
Figure 10.16: Danaher Corporation: Net Revenue (by Region), 2018-2019
Figure 10.17: Medtronic plc: Overall Financials ($Million), 2018-2020
Figure 10.18: Medtronic plc: Net Revenue (by Segment), 2018-2020
Figure 10.19: Medtronic plc: Net Revenue (by Region), 2018-2020
Figure 10.20: Olympus Corporation: Overall Financials ($Million), 2018-2020
Figure 10.21: Olympus Corporation: Net Revenue (by Segment), 2018-2020
Figure 10.22: Olympus Corporation: Net Revenue (by Region), 2018-2020
Figure 10.23: Renishaw plc: Overall Financials ($Million), 2018-2020
Figure 10.24: Renishaw plc: Net Revenue (by Segment), 2018-2020
Figure 10.25: Renishaw plc: Net Revenue (by Region), 2018-2020
Figure 10.26: Stryker Corporation: Overall Financials ($Million), 2017-2019
Figure 10.27: Stryker Corporation: Net Revenue (by Segment), 2017-2019
Figure 10.28: Stryker Corporation: Net Revenue (by Region), 2017-2019
Figure 10.29: Zimmer Biomet Holdings, Inc.: Overall Financials ($Million), 2017-2019
Figure 10.30: Zimmer Biomet Holdings, Inc.: Net Revenue (by Product Category), 2017-2019
Figure 10.31: Zimmer Biomet Holdings, Inc.: Net Revenue (by Region), 2017-2019